❇️ New Article available #OpenAccess Why does #asthma cost the US economy roughly 100 times more than it costs low-income countries — even though LMICs carry the larger share of the disease burden? Read the full paper: www.thelancet.com/journals/lan...

📊 The August issue of The Lancet Respiratory Medicine is out — from equitable #ILD care to new trial data in children's oxygen therapy, severe #asthma biologics, and reproductive health in #cysticfibrosis. Check out the full issue here: www.thelancet.com/issue/S2213-...

🔔 Discover The Lancet Surgery & Anaesthesiology, a new journal with a sharp clinical focus, dedicated to advancing science across the full extent of #surgery, #anaesthesiology, and #perioperative specialties, across the age spectrum, and across the globe: spkl.io/633237JQbc

📊 New Article available #OpenAccess 📈 FEF25–75% trajectories from age 7 to 53 years, associations with childhood and parental preconception factors, and midlife COPD risk: a prospective cohort study Could your risk of #COPD be shaped before you were even born? www.thelancet.com/journals/lan...

Does transformative CF treatment mean transformative reproductive outcomes — and why does the answer differ for men and women? Read the full paper: www.thelancet.com/journals/lan... #CysticFibrosis #CFTRModulators #ReproductiveHealth #LancetRespiratoryMedicine #Pulmonology #WomensHealth #CFCare

From @lancetrespirmed.bsky.social 🫁 #Sugammadex decreased the incidence of postoperative pulmonary complications or mortality compared with #neostigmine in older adults who had major abdominal or #ThoracicSurgery under #GeneralAnesthesia. @katy-skier.bsky.social @prof-nancy-devlin.bsky.social

Postoperative Pulmonary Complications: Sugammadex Outperforms Neostigmine

Sugammadex lowers the risk for postoperative pulmonary complications vs neostigmine after major abdominal or thoracic surgery in older adults.

pulmonologyadvisor.com

📮 July issue out now! Check out the full issue here: www.thelancet.com/issue/S2213-... 📜 Editorial - Dying with Dignity—time to cut the red tape www.thelancet.com/journals/lan... 📰 News Barriers limit oxygen therapy in Nigeria, Kenya, and Uganda by Paul Adepoju www.thelancet.com/journals/lan...

We are the world-leading journal, ranking #1 in:   Journal Impact Factor (34·7) in respiratory system and #CriticalCareMedicine  Scopus CiteScore (48·1) in pulmonary and #RespiratoryMedicine  Explore our high impact and global reach: hubs.li/Q04k_nNQ0    #Pulmonology #pulmcc

Peer review is stronger when reviewers reflect the breadth of global health expertise. If you author or review for a Lancet journal, update your Editorial Manager profile with your health equity & discrimination expertise. tinyurl.com/yrxfvsbm

🗞️ News - Trump Administration sparks furore and resignations over fruit-flavoured #vape authorisations 🔹 White House overrules objections from FDA commissioner, ordering the agency to authorise two fruit-flavoured #eCigarette products @bryantfurlow.bsky.social 🖇️ www.thelancet.com/journals/lan...

Trump Administration sparks furore and resignations over fruit-flavoured vape authorisations

On May 5, the White House overruled objections from US Food and Drug Administration (FDA) commissioner Marty Makary and ordered the agency to authorise sales of two fruit-flavoured e-cigarette product...

thelancet.com

New Article available #OpenAccess 📌 Prevalence and disease trajectories of pulmonary fibrosis of childhood interstitial lung disease: a register-based, multicentre observational study #ILD #chILD #PulmonaryFibrosis 🖇️ www.thelancet.com/journals/lan...

🎙️New Podcast Andrew Bush, Heather Zar, and Fernando de Benedictis on how inhaled corticosteroids have changed the treatment of asthma www.thelancet.com/audio-do/and... Check out the full paper here: www.thelancet.com/journals/lan...

50 years on: how inhaled corticosteroids have changed the treatment of asthma

Inhaled corticosteroids are the foundation of asthma therapy and now, 50 years on from their introduction, is an appropriate time to summarise some of the key studies that have progressed the field. W...

thelancet.com

📊 New Article available #OpenAccess 📌Sugammadex versus neostigmine for reversal of neuromuscular blockade and postoperative pulmonary complications (SNaPP): an international, randomised, controlled, phase 4 trial 🔗 www.thelancet.com/journals/lan...

Sugammadex versus neostigmine for reversal of neuromuscular blockade and postoperative pulmonary complications (SNaPP): an international, randomised, controlled, phase 4 trial

Sugammadex reduced the incidence of postoperative pulmonary complications or death compared with neostigmine. The risk reduction was small with atelectasis of uncertain clinical significance being the...

thelancet.com

Today is #CleanAirDay Read our latest Editorial - Clean Air Day: breathe locally, plan globally www.thelancet.com/journals/lan...

From @lancetrespirmed.bsky.social 🫁 The link between 60-day mortality and personalized, best-practice mechanical ventilation in patients with #AcuteRespiratoryDistressSyndrome may be stronger in those with hypoinflammatory vs hyperinflammatory ARDS.

In ARDS, Mortality Risk With Mechanical Ventilation Varies by Phenotype

The link between 60-day mortality and MV in patients with ARDS may be stronger in those with hypoinflammatory vs hyperinflammatory ARDS.

pulmonologyadvisor.com

💡 New Spotlight: Africa's inhaler dilemma Esther Nakkazi reports on the issues of cost, climate, and care www.thelancet.com/journals/lan...

Africa's inhaler dilemma: balancing cost, climate, and care

When baby Sidrah Isaacs was born, she appeared well. At around 6 weeks of age, her mother, Sasha Leigh, began to notice concerning symptoms, including a silent cough, a weak cry, and breathing difficu...

thelancet.com

It's official! The SNaPP trial @anzcactn.bsky.social findings are out, published today @lancetrespirmed.bsky.social, a four year trial with principal investigator @katy-skier.bsky.social.

Global study highlights hidden pandemic of lung complications - ANZCA

A “hidden pandemic” of lung complications after surgery has been highlighted by an international study led by Australian anaesthetists that has found how a newer muscle relaxant reversal drug can help...

anzca.edu.au

🌅 Check out the #SUNRISE phase 3 trial of tezepelumab in reducing OCS use in severe, OCS-dependent #asthma 🟥Efficacy and safety of tezepelumab vs placebo in reducing oral corticosteroid use in adults with severe, oral corticosteroid-dependent #asthma (SUNRISE) tinyurl.com/6h8xtr8w

Efficacy and safety of tezepelumab versus placebo in reducing oral corticosteroid use in adults with severe, oral corticosteroid-dependent asthma (SUNRISE): a multicentre, placebo-controlled, double-b...

In this study, tezepelumab treatment led to greater reductions from baseline in daily oral corticosteroid dose than placebo at week 28 despite early study termination. No safety concerns were identifi...

thelancet.com

🏥 June issue of The Lancet Respiratory Medicine available online and in print now! Check out the full issue here: www.thelancet.com/issue/S2213-... 📜 Editorial Clean Air Day: breathe locally, plan globally www.thelancet.com/journals/lan...

🗞️ News: 2026 #GINA report for #asthma On May 5, 2025, the Global Initiative for Asthma published the 2026 update to their Global Strategy for Asthma Management and Prevention. Check out the major updates here: www.thelancet.com/journals/lan... Written by Priya Venkatesan

2026 GINA report for asthma

On May 5, 2025, the Global Initiative For Asthma (GINA) published the 2026 update to their Global Strategy for Asthma Management and Prevention. On the same date, an online discussion hosted by GINA p...

thelancet.com

📰 New Correspondence: Toxic skies of war "Environmental agencies and health organisations should address war as a dimension of increased environmental risk and hold those responsible to account for the environmental damage caused by warfare actions." www.thelancet.com/journals/lan...

Toxic skies of war

Recent reports indicate that the burden of chronic respiratory diseases has increased by 80% in the Middle East and Northern Africa region between 1990 and 2019,1 and air pollution in the region, part...

thelancet.com

🚨New Article #OpenAccess #Asthma exacerbation profile of benralizumab for severe eosinophilic asthma (the BenRex study) Findings suggested that eosinophilic inflammation is not involved in exacerbations when a patient is being treated with benralizumab www.thelancet.com/journals/lan...

Asthma exacerbation profile of benralizumab for severe eosinophilic asthma (the BenRex study): a multicentre, prospective cohort study

Our findings suggested that eosinophilic inflammation is not involved in exacerbations when a patient is being treated with benralizumab. Airway neutrophilia, viral pathogens, and alteration of the sp...

thelancet.com

Inhaled corticosteroids are the foundation of asthma therapy and play a crucial role in reducing the risk of asthma attacks. In @lancetrespirmed.bsky.social, a Personal View discusses how inhaled corticosteroids have changed asthma treatment over the last 50 years: spkl.io/63323ACkhX

🗞️ News: Barriers limit oxygen therapy in Nigeria, Kenya, and Uganda 🔹 WHO classifies medical oxygen as an essential medicine, yet access remains persistently unequal across settings. 🖇️ www.thelancet.com/journals/lan... Written by Paul Adepoju

🚨 New publication alert 📈 Epidemiology, ventilation management, and clinical outcomes in children (PRoVENT-PED): first results from the 10-year, investigator-initiated, international, multicentre, prospective cohort study 🖇️ www.thelancet.com/journals/lan...

Epidemiology, ventilation management, and clinical outcomes in children (PRoVENT-PED): first results from the 10-year, investigator-initiated, international, multicentre, prospective cohort study

Ventilation management in children varies substantially by age and PARDS status. Among potentially modifiable ventilation factors, only PEEP, ΔP, and FiO2 were associated with 28-day mortality.

thelancet.com

📰 Check out our comprehensive new Review 🏥 Respiratory infections due to human common cold coronaviruses, #SARS-CoV, #MERS-CoV, and SARS-CoV-2: epidemiology, pathogenesis, clinical features, diagnostics, therapeutics, and vaccine landscapes 🖇️ www.thelancet.com/journals/lan...

Respiratory infections due to human common cold coronaviruses, SARS-CoV, MERS-CoV, and SARS-CoV-2: epidemiology, pathogenesis, clinical features, diagnostics, therapeutics, and vaccine landscapes

Over the past half-century, perceptions of human coronaviruses have evolved from their initial characterisation as causes of the common cold to recognition of their capacity to trigger severe disease ...

thelancet.com

Here is the paper @lancetrespirmed.bsky.social (3/3) #IDSky #TBSky www.thelancet.com/journals/lan...

Whole genome sequencing precision medicine strategy to shorten treatment for rifampicin-resistant tuberculosis (SMARTT): a pragmatic, randomised, single-blind phase 4 trial

Using WGS and AI to select regimens with optimal drug features had similar bacteriological and superior clinical efficacy compared with standard of care and was safe. Future trials should evaluate the...

thelancet.com

📰 Explore The Lancet Respiratory Medicine’s May 2026 issue, out now online and in print: www.thelancet.com/journals/lan... 📜 Our Editorial this month is on "Campaigning to improve #sepsis recognition and outcomes" www.thelancet.com/journals/lan...

📜New Editorial: Campaigning to improve #sepsis recognition and outcomes Read in full here: www.thelancet.com/journals/lan...

Campaigning to improve sepsis recognition and outcomes

Sepsis accounts for around a third of global deaths, with an estimated 166 million cases and 21·4 million all-cause sepsis-related deaths according to a recent study from the Global Sepsis Collaborato...

thelancet.com

🍃 Our April Issue is out now! Check out the full issue here: www.thelancet.com/issue/S2213-... The issue features three key Articles, available #OpenAccess, as well as News on tobacco control in the US and Asthma in India